# HOST - DAPT Duration According the Bleeding Risk

> **NCT05631769** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 4900 (estimated)

## Conditions studied

- Coronary Artery Disease
- Acute Myocardial Infarction
- Stable Angina

## Interventions

- **DRUG:** Dual antiplatelet agent duration

## Key facts

- **NCT ID:** NCT05631769
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-24
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 4900 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05631769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05631769, "HOST - DAPT Duration According the Bleeding Risk". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05631769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*